nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—CYP2C9—brain cancer	0.465	1	CbGaD
Simvastatin—UGT1A1—Etoposide—brain cancer	0.0602	0.176	CbGbCtD
Simvastatin—CYP2D6—Lomustine—brain cancer	0.0466	0.136	CbGbCtD
Simvastatin—ABCC2—Carboplatin—brain cancer	0.0436	0.128	CbGbCtD
Simvastatin—ABCC2—Etoposide—brain cancer	0.0366	0.107	CbGbCtD
Simvastatin—CYP2D6—Hydroxyurea—brain cancer	0.0353	0.103	CbGbCtD
Simvastatin—CYP3A4—Temozolomide—brain cancer	0.0348	0.102	CbGbCtD
Simvastatin—CYP3A4—Lomustine—brain cancer	0.0296	0.0866	CbGbCtD
Simvastatin—CYP3A5—Etoposide—brain cancer	0.0183	0.0537	CbGbCtD
Simvastatin—CYP2C8—Etoposide—brain cancer	0.0176	0.0516	CbGbCtD
Simvastatin—ABCB1—Etoposide—brain cancer	0.0119	0.0349	CbGbCtD
Simvastatin—CYP3A4—Etoposide—brain cancer	0.00715	0.0209	CbGbCtD
Simvastatin—ITGB2—endothelium—brain cancer	0.00366	0.147	CbGeAlD
Simvastatin—Lovastatin—CYP2C9—brain cancer	0.00213	0.5	CrCbGaD
Simvastatin—Pravastatin—CYP2C9—brain cancer	0.00213	0.5	CrCbGaD
Simvastatin—ITGB2—midbrain—brain cancer	0.00118	0.0472	CbGeAlD
Simvastatin—ITGB2—endocrine gland—brain cancer	0.00103	0.0414	CbGeAlD
Simvastatin—ITGB2—head—brain cancer	0.00102	0.0409	CbGeAlD
Simvastatin—ITGB2—central nervous system—brain cancer	0.000931	0.0373	CbGeAlD
Simvastatin—ITGB2—cerebellum—brain cancer	0.00091	0.0365	CbGeAlD
Simvastatin—UGT1A3—endocrine gland—brain cancer	0.00087	0.0349	CbGeAlD
Simvastatin—Endocrine disorder—Temozolomide—brain cancer	0.00083	0.00767	CcSEcCtD
Simvastatin—Alopecia—Lomustine—brain cancer	0.000796	0.00735	CcSEcCtD
Simvastatin—Interstitial lung disease—Etoposide—brain cancer	0.000778	0.00719	CcSEcCtD
Simvastatin—Drug interaction—Carmustine—brain cancer	0.000768	0.00709	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.000744	0.00688	CcSEcCtD
Simvastatin—ITGB2—brain—brain cancer	0.000739	0.0296	CbGeAlD
Simvastatin—Infection—Carboplatin—brain cancer	0.000727	0.00671	CcSEcCtD
Simvastatin—Hepatic failure—Hydroxyurea—brain cancer	0.000712	0.00658	CcSEcCtD
Simvastatin—Eosinophilia—Procarbazine—brain cancer	0.000707	0.00653	CcSEcCtD
Simvastatin—Leukopenia—Lomustine—brain cancer	0.000702	0.00648	CcSEcCtD
Simvastatin—Pancreatitis—Procarbazine—brain cancer	0.0007	0.00647	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Temozolomide—brain cancer	0.000688	0.00636	CcSEcCtD
Simvastatin—Photosensitivity reaction—Procarbazine—brain cancer	0.000652	0.00602	CcSEcCtD
Simvastatin—Gynaecomastia—Carmustine—brain cancer	0.000637	0.00589	CcSEcCtD
Simvastatin—Infection—Lomustine—brain cancer	0.000636	0.00587	CcSEcCtD
Simvastatin—Thrombocytopenia—Lomustine—brain cancer	0.000626	0.00579	CcSEcCtD
Simvastatin—Pain—Carboplatin—brain cancer	0.000625	0.00578	CcSEcCtD
Simvastatin—Neuropathy peripheral—Procarbazine—brain cancer	0.000624	0.00577	CcSEcCtD
Simvastatin—Jaundice—Procarbazine—brain cancer	0.000621	0.00574	CcSEcCtD
Simvastatin—Anorexia—Lomustine—brain cancer	0.00061	0.00563	CcSEcCtD
Simvastatin—Diabetes mellitus—Carmustine—brain cancer	0.000594	0.00549	CcSEcCtD
Simvastatin—Swelling—Carmustine—brain cancer	0.000586	0.00541	CcSEcCtD
Simvastatin—HMGCR—telencephalon—brain cancer	0.000585	0.0234	CbGeAlD
Simvastatin—Body temperature increased—Carboplatin—brain cancer	0.000578	0.00534	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.000574	0.00531	CcSEcCtD
Simvastatin—Inflammation—Etoposide—brain cancer	0.000568	0.00525	CcSEcCtD
Simvastatin—Vascular purpura—Temozolomide—brain cancer	0.000559	0.00516	CcSEcCtD
Simvastatin—Decreased appetite—Lomustine—brain cancer	0.000556	0.00514	CcSEcCtD
Simvastatin—Hepatic failure—Temozolomide—brain cancer	0.000556	0.00514	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Etoposide—brain cancer	0.000551	0.00509	CcSEcCtD
Simvastatin—Amnesia—Carmustine—brain cancer	0.00055	0.00508	CcSEcCtD
Simvastatin—Pancreatitis—Hydroxyurea—brain cancer	0.000542	0.00501	CcSEcCtD
Simvastatin—Amnesia—Temozolomide—brain cancer	0.000532	0.00491	CcSEcCtD
Simvastatin—Flushing—Procarbazine—brain cancer	0.000531	0.0049	CcSEcCtD
Simvastatin—Purpura—Temozolomide—brain cancer	0.000518	0.00479	CcSEcCtD
Simvastatin—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000517	0.00925	CbGpPWpGaD
Simvastatin—CYP3A7—endocrine gland—brain cancer	0.000515	0.0207	CbGeAlD
Simvastatin—Chills—Procarbazine—brain cancer	0.000513	0.00474	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—BSG—brain cancer	0.000507	0.00907	CbGpPWpGaD
Simvastatin—Body temperature increased—Lomustine—brain cancer	0.000506	0.00467	CcSEcCtD
Simvastatin—Alopecia—Procarbazine—brain cancer	0.000505	0.00467	CcSEcCtD
Simvastatin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000505	0.00904	CbGpPWpGaD
Simvastatin—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000503	0.009	CbGpPWpGaD
Simvastatin—UGT2B7—endocrine gland—brain cancer	0.0005	0.02	CbGeAlD
Simvastatin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000492	0.00881	CbGpPWpGaD
Simvastatin—HMGCR—gonad—brain cancer	0.000488	0.0196	CbGeAlD
Simvastatin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000483	0.00446	CcSEcCtD
Simvastatin—HMGCR—pituitary gland—brain cancer	0.000476	0.0191	CbGeAlD
Simvastatin—Tremor—Procarbazine—brain cancer	0.000466	0.00431	CcSEcCtD
Simvastatin—Anaemia—Procarbazine—brain cancer	0.00046	0.00425	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.00046	0.00425	CcSEcCtD
Simvastatin—HMGCR—medulla oblongata—brain cancer	0.00046	0.0184	CbGeAlD
Simvastatin—Muscular weakness—Carmustine—brain cancer	0.000456	0.00421	CcSEcCtD
Simvastatin—SLCO1A2—telencephalon—brain cancer	0.000456	0.0183	CbGeAlD
Simvastatin—Swelling—Etoposide—brain cancer	0.000453	0.00419	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00045	0.00416	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—MPL—brain cancer	0.000446	0.00798	CbGpPWpGaD
Simvastatin—Leukopenia—Procarbazine—brain cancer	0.000446	0.00412	CcSEcCtD
Simvastatin—Muscular weakness—Temozolomide—brain cancer	0.000441	0.00407	CcSEcCtD
Simvastatin—ITGB2—Hemostasis—S100A10—brain cancer	0.000427	0.00765	CbGpPWpGaD
Simvastatin—UGT1A1—Irinotecan Pathway—APC—brain cancer	0.000427	0.00764	CbGpPWpGaD
Simvastatin—UGT1A1—endocrine gland—brain cancer	0.000425	0.017	CbGeAlD
Simvastatin—Myalgia—Procarbazine—brain cancer	0.000424	0.00391	CcSEcCtD
Simvastatin—Arthralgia—Procarbazine—brain cancer	0.000424	0.00391	CcSEcCtD
Simvastatin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000423	0.00756	CbGpPWpGaD
Simvastatin—Anxiety—Procarbazine—brain cancer	0.000422	0.0039	CcSEcCtD
Simvastatin—HMGCR—midbrain—brain cancer	0.00042	0.0168	CbGeAlD
Simvastatin—CYP2D6—hindbrain—brain cancer	0.000417	0.0167	CbGeAlD
Simvastatin—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000417	0.00746	CbGpPWpGaD
Simvastatin—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000416	0.00745	CbGpPWpGaD
Simvastatin—Bronchitis—Temozolomide—brain cancer	0.000415	0.00384	CcSEcCtD
Simvastatin—HMGCR—spinal cord—brain cancer	0.00041	0.0164	CbGeAlD
Simvastatin—Confusional state—Procarbazine—brain cancer	0.00041	0.00378	CcSEcCtD
Simvastatin—Vomiting—Lomustine—brain cancer	0.000407	0.00376	CcSEcCtD
Simvastatin—Oedema—Procarbazine—brain cancer	0.000406	0.00375	CcSEcCtD
Simvastatin—Infection—Procarbazine—brain cancer	0.000404	0.00373	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Temozolomide—brain cancer	0.000401	0.00371	CcSEcCtD
Simvastatin—Erectile dysfunction—Temozolomide—brain cancer	0.000398	0.00367	CcSEcCtD
Simvastatin—Thrombocytopenia—Procarbazine—brain cancer	0.000398	0.00367	CcSEcCtD
Simvastatin—Depression—Carmustine—brain cancer	0.000397	0.00367	CcSEcCtD
Simvastatin—Chills—Hydroxyurea—brain cancer	0.000397	0.00367	CcSEcCtD
Simvastatin—Photosensitivity reaction—Temozolomide—brain cancer	0.000394	0.00364	CcSEcCtD
Simvastatin—SLCO1B1—Irinotecan Pathway—APC—brain cancer	0.000391	0.007	CbGpPWpGaD
Simvastatin—Alopecia—Hydroxyurea—brain cancer	0.000391	0.00361	CcSEcCtD
Simvastatin—Neuropathy peripheral—Carmustine—brain cancer	0.000391	0.00361	CcSEcCtD
Simvastatin—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000391	0.00699	CbGpPWpGaD
Simvastatin—Anorexia—Procarbazine—brain cancer	0.000387	0.00358	CcSEcCtD
Simvastatin—Erythema—Hydroxyurea—brain cancer	0.000385	0.00356	CcSEcCtD
Simvastatin—Depression—Temozolomide—brain cancer	0.000384	0.00355	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000382	0.00353	CcSEcCtD
Simvastatin—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000381	0.00682	CbGpPWpGaD
Simvastatin—Nausea—Lomustine—brain cancer	0.00038	0.00351	CcSEcCtD
Simvastatin—Neuropathy peripheral—Temozolomide—brain cancer	0.000377	0.00349	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00037	0.00342	CcSEcCtD
Simvastatin—ITGB2—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—brain cancer	0.00037	0.00662	CbGpPWpGaD
Simvastatin—HMGCR—endocrine gland—brain cancer	0.000369	0.0148	CbGeAlD
Simvastatin—Insomnia—Procarbazine—brain cancer	0.000367	0.00339	CcSEcCtD
Simvastatin—Paraesthesia—Procarbazine—brain cancer	0.000365	0.00337	CcSEcCtD
Simvastatin—HMGCR—head—brain cancer	0.000364	0.0146	CbGeAlD
Simvastatin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000363	0.0065	CbGpPWpGaD
Simvastatin—Sinusitis—Temozolomide—brain cancer	0.000361	0.00334	CcSEcCtD
Simvastatin—Cramp muscle—Etoposide—brain cancer	0.00036	0.00333	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00036	0.00333	CcSEcCtD
Simvastatin—SLCO1A2—medulla oblongata—brain cancer	0.000358	0.0144	CbGeAlD
Simvastatin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000357	0.0033	CcSEcCtD
Simvastatin—Anaemia—Hydroxyurea—brain cancer	0.000356	0.00329	CcSEcCtD
Simvastatin—SLCO1B1—endocrine gland—brain cancer	0.000353	0.0142	CbGeAlD
Simvastatin—Decreased appetite—Procarbazine—brain cancer	0.000353	0.00326	CcSEcCtD
Simvastatin—Fatigue—Procarbazine—brain cancer	0.00035	0.00324	CcSEcCtD
Simvastatin—Malaise—Hydroxyurea—brain cancer	0.000347	0.00321	CcSEcCtD
Simvastatin—Constipation—Procarbazine—brain cancer	0.000347	0.00321	CcSEcCtD
Simvastatin—Pain—Procarbazine—brain cancer	0.000347	0.00321	CcSEcCtD
Simvastatin—Hepatitis—Temozolomide—brain cancer	0.000346	0.00319	CcSEcCtD
Simvastatin—Leukopenia—Hydroxyurea—brain cancer	0.000345	0.00319	CcSEcCtD
Simvastatin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000343	0.00613	CbGpPWpGaD
Simvastatin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000342	0.00612	CbGpPWpGaD
Simvastatin—Feeling abnormal—Procarbazine—brain cancer	0.000335	0.00309	CcSEcCtD
Simvastatin—HMGCR—central nervous system—brain cancer	0.000332	0.0133	CbGeAlD
Simvastatin—Gastrointestinal pain—Procarbazine—brain cancer	0.000332	0.00307	CcSEcCtD
Simvastatin—Flushing—Carmustine—brain cancer	0.000332	0.00307	CcSEcCtD
Simvastatin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000329	0.00589	CbGpPWpGaD
Simvastatin—SLCO1A2—midbrain—brain cancer	0.000327	0.0131	CbGeAlD
Simvastatin—Erythema multiforme—Temozolomide—brain cancer	0.000327	0.00302	CcSEcCtD
Simvastatin—HMGCR—cerebellum—brain cancer	0.000325	0.013	CbGeAlD
Simvastatin—Discomfort—Hydroxyurea—brain cancer	0.000324	0.00299	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—VAV1—brain cancer	0.000324	0.00579	CbGpPWpGaD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000323	0.00578	CbGpPWpGaD
Simvastatin—Urticaria—Procarbazine—brain cancer	0.000323	0.00298	CcSEcCtD
Simvastatin—Body temperature increased—Procarbazine—brain cancer	0.000321	0.00297	CcSEcCtD
Simvastatin—Abdominal pain—Procarbazine—brain cancer	0.000321	0.00297	CcSEcCtD
Simvastatin—Flushing—Temozolomide—brain cancer	0.000321	0.00296	CcSEcCtD
Simvastatin—SLCO1A2—spinal cord—brain cancer	0.000319	0.0128	CbGeAlD
Simvastatin—Alopecia—Carmustine—brain cancer	0.000316	0.00292	CcSEcCtD
Simvastatin—ABCB1—blood vessel—brain cancer	0.000315	0.0126	CbGeAlD
Simvastatin—Oedema—Hydroxyurea—brain cancer	0.000314	0.0029	CcSEcCtD
Simvastatin—Mental disorder—Carmustine—brain cancer	0.000313	0.0029	CcSEcCtD
Simvastatin—UGT1A3—Biological oxidations—CYP2C9—brain cancer	0.000313	0.0056	CbGpPWpGaD
Simvastatin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000313	0.00559	CbGpPWpGaD
Simvastatin—Infection—Hydroxyurea—brain cancer	0.000312	0.00289	CcSEcCtD
Simvastatin—Erythema—Carmustine—brain cancer	0.000311	0.00288	CcSEcCtD
Simvastatin—Chills—Temozolomide—brain cancer	0.00031	0.00287	CcSEcCtD
Simvastatin—UGT1A3—Metapathway biotransformation—CYP2C9—brain cancer	0.000309	0.00553	CbGpPWpGaD
Simvastatin—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000308	0.00552	CbGpPWpGaD
Simvastatin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000308	0.00284	CcSEcCtD
Simvastatin—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000306	0.00548	CbGpPWpGaD
Simvastatin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000305	0.00282	CcSEcCtD
Simvastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000305	0.00547	CbGpPWpGaD
Simvastatin—Alopecia—Temozolomide—brain cancer	0.000305	0.00282	CcSEcCtD
Simvastatin—Mental disorder—Temozolomide—brain cancer	0.000303	0.0028	CcSEcCtD
Simvastatin—Neuropathy peripheral—Etoposide—brain cancer	0.000302	0.00279	CcSEcCtD
Simvastatin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000301	0.00539	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—BSG—brain cancer	0.000301	0.00539	CbGpPWpGaD
Simvastatin—Erythema—Temozolomide—brain cancer	0.000301	0.00278	CcSEcCtD
Simvastatin—Jaundice—Etoposide—brain cancer	0.0003	0.00277	CcSEcCtD
Simvastatin—Anorexia—Hydroxyurea—brain cancer	0.0003	0.00277	CcSEcCtD
Simvastatin—Hypersensitivity—Procarbazine—brain cancer	0.000299	0.00276	CcSEcCtD
Simvastatin—HMGCR—SREBP signalling—SIRT1—brain cancer	0.000297	0.00532	CbGpPWpGaD
Simvastatin—Dysgeusia—Temozolomide—brain cancer	0.000295	0.00272	CcSEcCtD
Simvastatin—Vision blurred—Carmustine—brain cancer	0.000293	0.00271	CcSEcCtD
Simvastatin—Tremor—Carmustine—brain cancer	0.000292	0.0027	CcSEcCtD
Simvastatin—Asthenia—Procarbazine—brain cancer	0.000291	0.00269	CcSEcCtD
Simvastatin—Anaemia—Carmustine—brain cancer	0.000288	0.00266	CcSEcCtD
Simvastatin—SLCO1A2—endocrine gland—brain cancer	0.000288	0.0115	CbGeAlD
Simvastatin—Pruritus—Procarbazine—brain cancer	0.000287	0.00266	CcSEcCtD
Simvastatin—ITGB2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000286	0.00513	CbGpPWpGaD
Simvastatin—SLCO1A2—head—brain cancer	0.000284	0.0114	CbGeAlD
Simvastatin—Vision blurred—Temozolomide—brain cancer	0.000284	0.00262	CcSEcCtD
Simvastatin—Tremor—Temozolomide—brain cancer	0.000282	0.0026	CcSEcCtD
Simvastatin—Dyspnoea—Hydroxyurea—brain cancer	0.00028	0.00259	CcSEcCtD
Simvastatin—Ill-defined disorder—Temozolomide—brain cancer	0.000279	0.00258	CcSEcCtD
Simvastatin—Leukopenia—Carmustine—brain cancer	0.000279	0.00258	CcSEcCtD
Simvastatin—Anaemia—Temozolomide—brain cancer	0.000278	0.00257	CcSEcCtD
Simvastatin—Diarrhoea—Procarbazine—brain cancer	0.000278	0.00257	CcSEcCtD
Simvastatin—Dyspepsia—Hydroxyurea—brain cancer	0.000277	0.00256	CcSEcCtD
Simvastatin—Angioedema—Temozolomide—brain cancer	0.000275	0.00254	CcSEcCtD
Simvastatin—Decreased appetite—Hydroxyurea—brain cancer	0.000273	0.00252	CcSEcCtD
Simvastatin—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000273	0.00489	CbGpPWpGaD
Simvastatin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000271	0.00251	CcSEcCtD
Simvastatin—Malaise—Temozolomide—brain cancer	0.000271	0.00251	CcSEcCtD
Simvastatin—Fatigue—Hydroxyurea—brain cancer	0.000271	0.0025	CcSEcCtD
Simvastatin—Vertigo—Temozolomide—brain cancer	0.00027	0.0025	CcSEcCtD
Simvastatin—Leukopenia—Temozolomide—brain cancer	0.000269	0.00249	CcSEcCtD
Simvastatin—Constipation—Hydroxyurea—brain cancer	0.000269	0.00248	CcSEcCtD
Simvastatin—Pain—Hydroxyurea—brain cancer	0.000269	0.00248	CcSEcCtD
Simvastatin—Dizziness—Procarbazine—brain cancer	0.000269	0.00248	CcSEcCtD
Simvastatin—ABCC2—endocrine gland—brain cancer	0.000268	0.0107	CbGeAlD
Simvastatin—UGT2B7—Biological oxidations—CYP2C9—brain cancer	0.000266	0.00477	CbGpPWpGaD
Simvastatin—Myalgia—Carmustine—brain cancer	0.000265	0.00245	CcSEcCtD
Simvastatin—Chest pain—Carmustine—brain cancer	0.000265	0.00245	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—PDGFRA—brain cancer	0.000265	0.00474	CbGpPWpGaD
Simvastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000265	0.00473	CbGpPWpGaD
Simvastatin—Anxiety—Carmustine—brain cancer	0.000264	0.00244	CcSEcCtD
Simvastatin—HMGCR—brain—brain cancer	0.000264	0.0106	CbGeAlD
Simvastatin—UGT2B7—Metapathway biotransformation—CYP2C9—brain cancer	0.000263	0.0047	CbGpPWpGaD
Simvastatin—Erythema multiforme—Etoposide—brain cancer	0.000262	0.00242	CcSEcCtD
Simvastatin—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000261	0.00467	CbGpPWpGaD
Simvastatin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000259	0.00464	CbGpPWpGaD
Simvastatin—CYP2C8—pituitary gland—brain cancer	0.000259	0.0104	CbGeAlD
Simvastatin—SLCO1A2—central nervous system—brain cancer	0.000259	0.0104	CbGeAlD
Simvastatin—Feeling abnormal—Hydroxyurea—brain cancer	0.000259	0.00239	CcSEcCtD
Simvastatin—Vomiting—Procarbazine—brain cancer	0.000258	0.00239	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—SPP1—brain cancer	0.000257	0.00461	CbGpPWpGaD
Simvastatin—Flushing—Etoposide—brain cancer	0.000257	0.00237	CcSEcCtD
Simvastatin—Confusional state—Carmustine—brain cancer	0.000256	0.00237	CcSEcCtD
Simvastatin—Myalgia—Temozolomide—brain cancer	0.000256	0.00237	CcSEcCtD
Simvastatin—Arthralgia—Temozolomide—brain cancer	0.000256	0.00237	CcSEcCtD
Simvastatin—Rash—Procarbazine—brain cancer	0.000256	0.00237	CcSEcCtD
Simvastatin—Dermatitis—Procarbazine—brain cancer	0.000256	0.00236	CcSEcCtD
Simvastatin—Anxiety—Temozolomide—brain cancer	0.000255	0.00236	CcSEcCtD
Simvastatin—Headache—Procarbazine—brain cancer	0.000254	0.00235	CcSEcCtD
Simvastatin—Oedema—Carmustine—brain cancer	0.000254	0.00235	CcSEcCtD
Simvastatin—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000253	0.00453	CbGpPWpGaD
Simvastatin—SLCO1A2—cerebellum—brain cancer	0.000253	0.0102	CbGeAlD
Simvastatin—Discomfort—Temozolomide—brain cancer	0.000253	0.00234	CcSEcCtD
Simvastatin—Infection—Carmustine—brain cancer	0.000252	0.00233	CcSEcCtD
Simvastatin—Thrombocytopenia—Carmustine—brain cancer	0.000249	0.0023	CcSEcCtD
Simvastatin—Body temperature increased—Hydroxyurea—brain cancer	0.000249	0.0023	CcSEcCtD
Simvastatin—Chills—Etoposide—brain cancer	0.000248	0.00229	CcSEcCtD
Simvastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000248	0.00443	CbGpPWpGaD
Simvastatin—Confusional state—Temozolomide—brain cancer	0.000248	0.00229	CcSEcCtD
Simvastatin—Anaphylactic shock—Temozolomide—brain cancer	0.000246	0.00227	CcSEcCtD
Simvastatin—Oedema—Temozolomide—brain cancer	0.000246	0.00227	CcSEcCtD
Simvastatin—Alopecia—Etoposide—brain cancer	0.000244	0.00226	CcSEcCtD
Simvastatin—Infection—Temozolomide—brain cancer	0.000244	0.00225	CcSEcCtD
Simvastatin—Anorexia—Carmustine—brain cancer	0.000242	0.00224	CcSEcCtD
Simvastatin—Nausea—Procarbazine—brain cancer	0.000241	0.00223	CcSEcCtD
Simvastatin—Thrombocytopenia—Temozolomide—brain cancer	0.00024	0.00222	CcSEcCtD
Simvastatin—CYP2D6—brainstem—brain cancer	0.000239	0.00959	CbGeAlD
Simvastatin—CYP2B6—gonad—brain cancer	0.000239	0.00956	CbGeAlD
Simvastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000236	0.00423	CbGpPWpGaD
Simvastatin—Dysgeusia—Etoposide—brain cancer	0.000236	0.00218	CcSEcCtD
Simvastatin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000235	0.0042	CbGpPWpGaD
Simvastatin—Anorexia—Temozolomide—brain cancer	0.000234	0.00216	CcSEcCtD
Simvastatin—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000233	0.00417	CbGpPWpGaD
Simvastatin—Hypersensitivity—Hydroxyurea—brain cancer	0.000232	0.00214	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000232	0.00214	CcSEcCtD
Simvastatin—Muscle spasms—Etoposide—brain cancer	0.000232	0.00214	CcSEcCtD
Simvastatin—CYP2C19—endocrine gland—brain cancer	0.00023	0.00923	CbGeAlD
Simvastatin—Insomnia—Carmustine—brain cancer	0.00023	0.00212	CcSEcCtD
Simvastatin—ITGB2—Toll Like Receptor 4 (TLR4) Cascade—RELA—brain cancer	0.000229	0.0041	CbGpPWpGaD
Simvastatin—Paraesthesia—Carmustine—brain cancer	0.000228	0.00211	CcSEcCtD
Simvastatin—Dyspnoea—Carmustine—brain cancer	0.000227	0.00209	CcSEcCtD
Simvastatin—Asthenia—Hydroxyurea—brain cancer	0.000226	0.00208	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000224	0.00207	CcSEcCtD
Simvastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000224	0.004	CbGpPWpGaD
Simvastatin—Ill-defined disorder—Etoposide—brain cancer	0.000223	0.00206	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000223	0.00399	CbGpPWpGaD
Simvastatin—Anaemia—Etoposide—brain cancer	0.000223	0.00206	CcSEcCtD
Simvastatin—Insomnia—Temozolomide—brain cancer	0.000222	0.00205	CcSEcCtD
Simvastatin—Decreased appetite—Carmustine—brain cancer	0.000221	0.00204	CcSEcCtD
Simvastatin—Paraesthesia—Temozolomide—brain cancer	0.000221	0.00204	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Carmustine—brain cancer	0.000219	0.00203	CcSEcCtD
Simvastatin—Dyspnoea—Temozolomide—brain cancer	0.000219	0.00202	CcSEcCtD
Simvastatin—Pain—Carmustine—brain cancer	0.000217	0.00201	CcSEcCtD
Simvastatin—Constipation—Carmustine—brain cancer	0.000217	0.00201	CcSEcCtD
Simvastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000217	0.00389	CbGpPWpGaD
Simvastatin—Malaise—Etoposide—brain cancer	0.000217	0.00201	CcSEcCtD
Simvastatin—UGT1A1—Biological oxidations—CYP2C9—brain cancer	0.000216	0.00387	CbGpPWpGaD
Simvastatin—Vertigo—Etoposide—brain cancer	0.000216	0.002	CcSEcCtD
Simvastatin—Dyspepsia—Temozolomide—brain cancer	0.000216	0.002	CcSEcCtD
Simvastatin—Leukopenia—Etoposide—brain cancer	0.000216	0.00199	CcSEcCtD
Simvastatin—Diarrhoea—Hydroxyurea—brain cancer	0.000215	0.00199	CcSEcCtD
Simvastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000215	0.00384	CbGpPWpGaD
Simvastatin—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000214	0.00384	CbGpPWpGaD
Simvastatin—Decreased appetite—Temozolomide—brain cancer	0.000213	0.00197	CcSEcCtD
Simvastatin—UGT1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000213	0.00382	CbGpPWpGaD
Simvastatin—CYP2D6—telencephalon—brain cancer	0.000212	0.00851	CbGeAlD
Simvastatin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000212	0.00196	CcSEcCtD
Simvastatin—Fatigue—Temozolomide—brain cancer	0.000212	0.00196	CcSEcCtD
Simvastatin—HMGCR—AMPK Signaling—PIK3CG—brain cancer	0.000212	0.00379	CbGpPWpGaD
Simvastatin—Pain—Temozolomide—brain cancer	0.00021	0.00194	CcSEcCtD
Simvastatin—Constipation—Temozolomide—brain cancer	0.00021	0.00194	CcSEcCtD
Simvastatin—Feeling abnormal—Carmustine—brain cancer	0.000209	0.00193	CcSEcCtD
Simvastatin—Dizziness—Hydroxyurea—brain cancer	0.000208	0.00192	CcSEcCtD
Simvastatin—Gastrointestinal pain—Carmustine—brain cancer	0.000208	0.00192	CcSEcCtD
Simvastatin—SLCO1A2—brain—brain cancer	0.000206	0.00825	CbGeAlD
Simvastatin—ITGB2—Focal Adhesion—PIK3CG—brain cancer	0.000206	0.00368	CbGpPWpGaD
Simvastatin—Chest pain—Etoposide—brain cancer	0.000205	0.00189	CcSEcCtD
Simvastatin—ITGB2—Toll-Like Receptors Cascades—RELA—brain cancer	0.000204	0.00365	CbGpPWpGaD
Simvastatin—Discomfort—Etoposide—brain cancer	0.000203	0.00187	CcSEcCtD
Simvastatin—Feeling abnormal—Temozolomide—brain cancer	0.000202	0.00187	CcSEcCtD
Simvastatin—CYP2C8—endocrine gland—brain cancer	0.000201	0.00806	CbGeAlD
Simvastatin—Abdominal pain—Carmustine—brain cancer	0.000201	0.00186	CcSEcCtD
Simvastatin—Body temperature increased—Carmustine—brain cancer	0.000201	0.00186	CcSEcCtD
Simvastatin—Gastrointestinal pain—Temozolomide—brain cancer	0.000201	0.00186	CcSEcCtD
Simvastatin—Vomiting—Hydroxyurea—brain cancer	0.0002	0.00185	CcSEcCtD
Simvastatin—Rash—Hydroxyurea—brain cancer	0.000198	0.00183	CcSEcCtD
Simvastatin—Confusional state—Etoposide—brain cancer	0.000198	0.00183	CcSEcCtD
Simvastatin—Dermatitis—Hydroxyurea—brain cancer	0.000198	0.00183	CcSEcCtD
Simvastatin—ITGB2—Extracellular matrix organization—SPP1—brain cancer	0.000198	0.00354	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TRPC6—brain cancer	0.000197	0.00353	CbGpPWpGaD
Simvastatin—Headache—Hydroxyurea—brain cancer	0.000197	0.00182	CcSEcCtD
Simvastatin—Anaphylactic shock—Etoposide—brain cancer	0.000197	0.00182	CcSEcCtD
Simvastatin—Infection—Etoposide—brain cancer	0.000195	0.0018	CcSEcCtD
Simvastatin—Urticaria—Temozolomide—brain cancer	0.000195	0.0018	CcSEcCtD
Simvastatin—Body temperature increased—Temozolomide—brain cancer	0.000194	0.00179	CcSEcCtD
Simvastatin—Abdominal pain—Temozolomide—brain cancer	0.000194	0.00179	CcSEcCtD
Simvastatin—Thrombocytopenia—Etoposide—brain cancer	0.000192	0.00178	CcSEcCtD
Simvastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000191	0.00343	CbGpPWpGaD
Simvastatin—Anorexia—Etoposide—brain cancer	0.000187	0.00173	CcSEcCtD
Simvastatin—Hypersensitivity—Carmustine—brain cancer	0.000187	0.00173	CcSEcCtD
Simvastatin—Nausea—Hydroxyurea—brain cancer	0.000187	0.00173	CcSEcCtD
Simvastatin—Asthenia—Carmustine—brain cancer	0.000182	0.00168	CcSEcCtD
Simvastatin—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000182	0.00326	CbGpPWpGaD
Simvastatin—CYP3A5—endocrine gland—brain cancer	0.000181	0.00727	CbGeAlD
Simvastatin—Hypersensitivity—Temozolomide—brain cancer	0.000181	0.00167	CcSEcCtD
Simvastatin—CYP2B6—endocrine gland—brain cancer	0.00018	0.00723	CbGeAlD
Simvastatin—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000179	0.00321	CbGpPWpGaD
Simvastatin—CYP2C9—endocrine gland—brain cancer	0.000179	0.00716	CbGeAlD
Simvastatin—CYP2B6—head—brain cancer	0.000178	0.00713	CbGeAlD
Simvastatin—Paraesthesia—Etoposide—brain cancer	0.000176	0.00163	CcSEcCtD
Simvastatin—Asthenia—Temozolomide—brain cancer	0.000176	0.00163	CcSEcCtD
Simvastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000176	0.00315	CbGpPWpGaD
Simvastatin—Dyspnoea—Etoposide—brain cancer	0.000175	0.00162	CcSEcCtD
Simvastatin—Diarrhoea—Carmustine—brain cancer	0.000174	0.00161	CcSEcCtD
Simvastatin—Pruritus—Temozolomide—brain cancer	0.000174	0.00161	CcSEcCtD
Simvastatin—Decreased appetite—Etoposide—brain cancer	0.000171	0.00158	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Etoposide—brain cancer	0.00017	0.00157	CcSEcCtD
Simvastatin—Fatigue—Etoposide—brain cancer	0.000169	0.00157	CcSEcCtD
Simvastatin—Dizziness—Carmustine—brain cancer	0.000168	0.00155	CcSEcCtD
Simvastatin—Constipation—Etoposide—brain cancer	0.000168	0.00155	CcSEcCtD
Simvastatin—Pain—Etoposide—brain cancer	0.000168	0.00155	CcSEcCtD
Simvastatin—Diarrhoea—Temozolomide—brain cancer	0.000168	0.00155	CcSEcCtD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000168	0.003	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—SKP2—brain cancer	0.000168	0.003	CbGpPWpGaD
Simvastatin—CYP2B6—central nervous system—brain cancer	0.000162	0.00651	CbGeAlD
Simvastatin—Dizziness—Temozolomide—brain cancer	0.000162	0.0015	CcSEcCtD
Simvastatin—Feeling abnormal—Etoposide—brain cancer	0.000162	0.0015	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000162	0.0029	CbGpPWpGaD
Simvastatin—Vomiting—Carmustine—brain cancer	0.000162	0.00149	CcSEcCtD
Simvastatin—Gastrointestinal pain—Etoposide—brain cancer	0.000161	0.00148	CcSEcCtD
Simvastatin—Rash—Carmustine—brain cancer	0.00016	0.00148	CcSEcCtD
Simvastatin—Dermatitis—Carmustine—brain cancer	0.00016	0.00148	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—ERBB2—brain cancer	0.00016	0.00286	CbGpPWpGaD
Simvastatin—Headache—Carmustine—brain cancer	0.000159	0.00147	CcSEcCtD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000159	0.00284	CbGpPWpGaD
Simvastatin—Vomiting—Temozolomide—brain cancer	0.000156	0.00144	CcSEcCtD
Simvastatin—Urticaria—Etoposide—brain cancer	0.000156	0.00144	CcSEcCtD
Simvastatin—Abdominal pain—Etoposide—brain cancer	0.000155	0.00144	CcSEcCtD
Simvastatin—Body temperature increased—Etoposide—brain cancer	0.000155	0.00144	CcSEcCtD
Simvastatin—Rash—Temozolomide—brain cancer	0.000155	0.00143	CcSEcCtD
Simvastatin—Dermatitis—Temozolomide—brain cancer	0.000155	0.00143	CcSEcCtD
Simvastatin—Headache—Temozolomide—brain cancer	0.000154	0.00142	CcSEcCtD
Simvastatin—ABCB1—telencephalon—brain cancer	0.000153	0.00612	CbGeAlD
Simvastatin—Nausea—Carmustine—brain cancer	0.000151	0.00139	CcSEcCtD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000149	0.00266	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—VAV1—brain cancer	0.000148	0.00265	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000148	0.00264	CbGpPWpGaD
Simvastatin—Nausea—Temozolomide—brain cancer	0.000146	0.00135	CcSEcCtD
Simvastatin—Hypersensitivity—Etoposide—brain cancer	0.000145	0.00134	CcSEcCtD
Simvastatin—CYP2C8—brain—brain cancer	0.000144	0.00576	CbGeAlD
Simvastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000142	0.00254	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—CCND1—brain cancer	0.000141	0.00252	CbGpPWpGaD
Simvastatin—Asthenia—Etoposide—brain cancer	0.000141	0.0013	CcSEcCtD
Simvastatin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00014	0.00251	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—CTNNB1—brain cancer	0.00014	0.0025	CbGpPWpGaD
Simvastatin—Pruritus—Etoposide—brain cancer	0.000139	0.00128	CcSEcCtD
Simvastatin—CYP3A4—endocrine gland—brain cancer	0.000136	0.00546	CbGeAlD
Simvastatin—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000135	0.00241	CbGpPWpGaD
Simvastatin—Diarrhoea—Etoposide—brain cancer	0.000134	0.00124	CcSEcCtD
Simvastatin—CYP2D6—endocrine gland—brain cancer	0.000134	0.00537	CbGeAlD
Simvastatin—ITGB2—Innate Immune System—VAV1—brain cancer	0.000133	0.00238	CbGpPWpGaD
Simvastatin—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000133	0.00238	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000132	0.00237	CbGpPWpGaD
Simvastatin—CYP2D6—head—brain cancer	0.000132	0.0053	CbGeAlD
Simvastatin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000132	0.00235	CbGpPWpGaD
Simvastatin—Dizziness—Etoposide—brain cancer	0.00013	0.0012	CcSEcCtD
Simvastatin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.00013	0.00232	CbGpPWpGaD
Simvastatin—CYP2B6—brain—brain cancer	0.000129	0.00517	CbGeAlD
Simvastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000128	0.0023	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—VAV1—brain cancer	0.000128	0.00229	CbGpPWpGaD
Simvastatin—ABCB1—gonad—brain cancer	0.000127	0.00511	CbGeAlD
Simvastatin—Vomiting—Etoposide—brain cancer	0.000125	0.00115	CcSEcCtD
Simvastatin—ABCB1—pituitary gland—brain cancer	0.000124	0.00499	CbGeAlD
Simvastatin—Rash—Etoposide—brain cancer	0.000124	0.00114	CcSEcCtD
Simvastatin—Dermatitis—Etoposide—brain cancer	0.000124	0.00114	CcSEcCtD
Simvastatin—Headache—Etoposide—brain cancer	0.000123	0.00114	CcSEcCtD
Simvastatin—ITGB2—Focal Adhesion—VEGFA—brain cancer	0.000123	0.0022	CbGpPWpGaD
Simvastatin—CYP3A4—central nervous system—brain cancer	0.000123	0.00492	CbGeAlD
Simvastatin—CYP2D6—central nervous system—brain cancer	0.000121	0.00484	CbGeAlD
Simvastatin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000121	0.00216	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.00012	0.00215	CbGpPWpGaD
Simvastatin—ABCB1—medulla oblongata—brain cancer	0.00012	0.00481	CbGeAlD
Simvastatin—CYP2D6—cerebellum—brain cancer	0.000118	0.00473	CbGeAlD
Simvastatin—Nausea—Etoposide—brain cancer	0.000117	0.00108	CcSEcCtD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000116	0.00208	CbGpPWpGaD
Simvastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000115	0.00206	CbGpPWpGaD
Simvastatin—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000114	0.00204	CbGpPWpGaD
Simvastatin—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000112	0.00201	CbGpPWpGaD
Simvastatin—ITGB2—Focal Adhesion—EGFR—brain cancer	0.000111	0.00198	CbGpPWpGaD
Simvastatin—ABCB1—midbrain—brain cancer	0.00011	0.0044	CbGeAlD
Simvastatin—ITGB2—Innate Immune System—PDGFRA—brain cancer	0.000109	0.00195	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000108	0.00193	CbGpPWpGaD
Simvastatin—ABCB1—spinal cord—brain cancer	0.000107	0.00429	CbGeAlD
Simvastatin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000107	0.00191	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—PDGFRA—brain cancer	0.000105	0.00187	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000102	0.00183	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—SKP2—brain cancer	0.000102	0.00182	CbGpPWpGaD
Simvastatin—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000102	0.00182	CbGpPWpGaD
Simvastatin—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.0001	0.00179	CbGpPWpGaD
Simvastatin—ABCB1—endocrine gland—brain cancer	9.63e-05	0.00386	CbGeAlD
Simvastatin—CYP2D6—brain—brain cancer	9.58e-05	0.00384	CbGeAlD
Simvastatin—ITGB2—Innate Immune System—IRS2—brain cancer	9.57e-05	0.00171	CbGpPWpGaD
Simvastatin—HMGCR—AMPK Signaling—TP53—brain cancer	9.56e-05	0.00171	CbGpPWpGaD
Simvastatin—ABCB1—head—brain cancer	9.51e-05	0.00381	CbGeAlD
Simvastatin—ITGB2—Hemostasis—PIK3CG—brain cancer	9.39e-05	0.00168	CbGpPWpGaD
Simvastatin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.35e-05	0.00167	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	9.3e-05	0.00166	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.27e-05	0.00166	CbGpPWpGaD
Simvastatin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.23e-05	0.00165	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—IRS2—brain cancer	9.19e-05	0.00164	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.9e-05	0.00159	CbGpPWpGaD
Simvastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	8.87e-05	0.00159	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—S100A10—brain cancer	8.74e-05	0.00156	CbGpPWpGaD
Simvastatin—ABCB1—central nervous system—brain cancer	8.68e-05	0.00348	CbGeAlD
Simvastatin—ABCB1—cerebellum—brain cancer	8.49e-05	0.0034	CbGeAlD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CCND1—brain cancer	7.75e-05	0.00139	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—VAV1—brain cancer	7.75e-05	0.00139	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	7.68e-05	0.00137	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.61e-05	0.00136	CbGpPWpGaD
Simvastatin—ABCB1—brain—brain cancer	6.89e-05	0.00276	CbGeAlD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	6.76e-05	0.00121	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—IL2—brain cancer	6.61e-05	0.00118	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—RELA—brain cancer	6.6e-05	0.00118	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—CYP2C9—brain cancer	6.57e-05	0.00118	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—ERBB2—brain cancer	6.56e-05	0.00117	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.51e-05	0.00117	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—PDGFRA—brain cancer	6.35e-05	0.00114	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—RELA—brain cancer	6.34e-05	0.00113	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.33e-05	0.00113	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—ERBB2—brain cancer	6.3e-05	0.00113	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—MYC—brain cancer	6.22e-05	0.00111	CbGpPWpGaD
Simvastatin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.12e-05	0.00109	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—brain cancer	6.08e-05	0.00109	CbGpPWpGaD
Simvastatin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.03e-05	0.00108	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—CTNNB1—brain cancer	5.74e-05	0.00103	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—VEGFA—brain cancer	5.61e-05	0.001	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—BSG—brain cancer	5.59e-05	0.001	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IRS2—brain cancer	5.57e-05	0.000998	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.57e-05	0.000996	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CYP2C9—brain cancer	5.36e-05	0.000958	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.28e-05	0.000944	CbGpPWpGaD
Simvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—brain cancer	5.11e-05	0.000914	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5e-05	0.000895	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—IDH1—brain cancer	4.8e-05	0.00086	CbGpPWpGaD
Simvastatin—SLCO1A2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.72e-05	0.000844	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—BSG—brain cancer	4.55e-05	0.000815	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CYP2C9—brain cancer	4.55e-05	0.000815	CbGpPWpGaD
Simvastatin—ITGB2—Innate Immune System—EGFR—brain cancer	4.55e-05	0.000814	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.38e-05	0.000783	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.37e-05	0.000783	CbGpPWpGaD
Simvastatin—ITGB2—Adaptive Immune System—EGFR—brain cancer	4.37e-05	0.000782	CbGpPWpGaD
Simvastatin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.3e-05	0.000769	CbGpPWpGaD
Simvastatin—ITGB2—Hemostasis—TP53—brain cancer	4.24e-05	0.000759	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.22e-05	0.000755	CbGpPWpGaD
Simvastatin—SLCO1B1—Transmembrane transport of small molecules—TRPC6—brain cancer	4.04e-05	0.000722	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CYP2C9—brain cancer	3.97e-05	0.00071	CbGpPWpGaD
Simvastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	3.95e-05	0.000708	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—IDH1—brain cancer	3.92e-05	0.000701	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.91e-05	0.0007	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.91e-05	0.000699	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—BSG—brain cancer	3.87e-05	0.000693	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—RELA—brain cancer	3.85e-05	0.000688	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—ERBB2—brain cancer	3.82e-05	0.000684	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—ENO2—brain cancer	3.8e-05	0.00068	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CYP2C9—brain cancer	3.7e-05	0.000662	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.47e-05	0.00062	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—IL2—brain cancer	3.46e-05	0.00062	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—IL2—brain cancer	3.45e-05	0.000618	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.4e-05	0.000608	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CYP2C9—brain cancer	3.39e-05	0.000607	CbGpPWpGaD
Simvastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.39e-05	0.000606	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—BSG—brain cancer	3.37e-05	0.000603	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.36e-05	0.000601	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—CTNNB1—brain cancer	3.34e-05	0.000598	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—IDH1—brain cancer	3.33e-05	0.000596	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.2e-05	0.000572	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—BSG—brain cancer	3.15e-05	0.000563	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.12e-05	0.000559	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CYP2C9—brain cancer	3.11e-05	0.000557	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—ENO2—brain cancer	3.1e-05	0.000554	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.97e-05	0.000532	CbGpPWpGaD
Simvastatin—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.93e-05	0.000525	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—STAT3—brain cancer	2.92e-05	0.000522	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—IDH1—brain cancer	2.9e-05	0.000519	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—BSG—brain cancer	2.88e-05	0.000516	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.86e-05	0.000511	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—IDH1—brain cancer	2.71e-05	0.000484	CbGpPWpGaD
Simvastatin—ITGB2—Immune System—EGFR—brain cancer	2.65e-05	0.000474	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—BSG—brain cancer	2.65e-05	0.000474	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—ENO2—brain cancer	2.63e-05	0.000471	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.6e-05	0.000466	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.57e-05	0.00046	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—IDH1—brain cancer	2.48e-05	0.000444	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.42e-05	0.000433	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.36e-05	0.000422	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP2C9—brain cancer	2.3e-05	0.000412	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—ENO2—brain cancer	2.29e-05	0.00041	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—IDH1—brain cancer	2.28e-05	0.000407	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP2C9—brain cancer	2.25e-05	0.000403	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ENO2—brain cancer	2.14e-05	0.000383	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.02e-05	0.000361	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.02e-05	0.000361	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ENO2—brain cancer	1.96e-05	0.000351	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—BSG—brain cancer	1.96e-05	0.00035	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP2C9—brain cancer	1.95e-05	0.000349	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—BSG—brain cancer	1.91e-05	0.000342	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.88e-05	0.000336	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ENO2—brain cancer	1.8e-05	0.000322	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CG—brain cancer	1.74e-05	0.000312	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP2C9—brain cancer	1.74e-05	0.000311	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP2C9—brain cancer	1.7e-05	0.000304	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—IDH1—brain cancer	1.68e-05	0.000301	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.66e-05	0.000297	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—BSG—brain cancer	1.66e-05	0.000296	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—IDH1—brain cancer	1.64e-05	0.000294	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.64e-05	0.000294	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000286	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—BSG—brain cancer	1.48e-05	0.000265	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.45e-05	0.000259	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—BSG—brain cancer	1.44e-05	0.000258	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—IDH1—brain cancer	1.42e-05	0.000255	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CG—brain cancer	1.42e-05	0.000254	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—BSG—brain cancer	1.36e-05	0.000243	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—BSG—brain cancer	1.35e-05	0.000241	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.33e-05	0.000238	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ENO2—brain cancer	1.33e-05	0.000238	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.3e-05	0.000233	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ENO2—brain cancer	1.3e-05	0.000233	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—IDH1—brain cancer	1.27e-05	0.000228	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—IDH1—brain cancer	1.24e-05	0.000222	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CG—brain cancer	1.21e-05	0.000216	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—IDH1—brain cancer	1.17e-05	0.000209	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.16e-05	0.000208	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—IDH1—brain cancer	1.16e-05	0.000208	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ENO2—brain cancer	1.13e-05	0.000202	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.09e-05	0.000196	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CG—brain cancer	1.05e-05	0.000188	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP2C9—brain cancer	1.05e-05	0.000187	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.04e-05	0.000185	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ENO2—brain cancer	1.01e-05	0.00018	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CG—brain cancer	9.81e-06	0.000176	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ENO2—brain cancer	9.81e-06	0.000176	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.44e-06	0.000169	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ENO2—brain cancer	9.25e-06	0.000165	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ENO2—brain cancer	9.17e-06	0.000164	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CG—brain cancer	8.99e-06	0.000161	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BSG—brain cancer	8.89e-06	0.000159	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CG—brain cancer	8.25e-06	0.000148	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—IDH1—brain cancer	7.65e-06	0.000137	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CG—brain cancer	6.1e-06	0.000109	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ENO2—brain cancer	6.05e-06	0.000108	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CG—brain cancer	5.96e-06	0.000107	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CG—brain cancer	5.17e-06	9.25e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CG—brain cancer	4.61e-06	8.25e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CG—brain cancer	4.5e-06	8.05e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CG—brain cancer	4.24e-06	7.59e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CG—brain cancer	4.2e-06	7.52e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CG—brain cancer	2.77e-06	4.96e-05	CbGpPWpGaD
